Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 2, 2011, Pages 183-192

  Jaissle, Gesine B ^a   Szurman, Peter ^a   Feltgen, Nicolas ^c   Spitzer, Bernhard ^d   Pielen, Amelie ^b   Rehak, Matus ^e   Spital, Georg ^f   Heimann, Heinrich ^g   Meyer, Carsten H ^h  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^f ST FRANZISKUS HOSPITAL   (Germany)

^g ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^h UNIVERSITY OF BONN   (Germany)

Author keywords

Bevacizumab; Branch retinal vein occlusion; Intravitreal therapy; Macular edema; Predictive factors; Prognostic facotrs for visual improvement

Indexed keywords

BEVACIZUMAB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CONTROLLED STUDY; DISEASE DURATION; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; EYE DISEASE; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROGNOSIS; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; RETREATMENT; RETROSPECTIVE STUDY; SYSTEMIC DISEASE; TREATMENT DURATION; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 79952452111     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1470-2     Document Type: Article

References (25)

1. The Branch Vein Occlusion Study Group 1984 Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 271 282
2. The SCORE Study Research Group 2009 A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6 Arch Ophthalmol 127 1115 1128 10.1001/archophthalmol. 2009.233
3. J Wroblewski JA Wells 3rd 2010 Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion Am J Ophthalmol 149 1 147 154 1:CAS:528:DC%2BD1MXhsFyhsLzN 10.1016/j.ajo.2009.08.005 19875087
4. MS Mandelcorn RK Nrusimhadevara 2004 Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases Retina 24 348 355 10.1097/00006982-200406000-00002 15187654 (Pubitemid 38780461)
5. U Mester P Dillinger 2002 Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion Retina 22 740 746 10.1097/00006982-200212000-00009 12476100 (Pubitemid 35462503)
6. S Fekrat MF Goldberg D Finkelstein 1998 Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion Arch Ophthalmol 116 43 52 1:STN:280:DyaK1c7gsF2rtw%3D%3D 9445207 (Pubitemid 28098893)
7. JN Weiss LA Bynoe 2001 Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion Ophthalmology 108 2249 2257 1:STN:280:DC%2BD3MnoslCmuw%3D%3D 10.1016/S0161-6420(01)00875-2 11733266 (Pubitemid 33096938)
8. H Noma H Funatsu M Yamasaki H Tsukamoto T Mimura T Sone T Hirayama H Tamura H Yamashita A Minamoto HK Mishima 2008 Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion Eye 22 42 48 1:CAS:528:DC%2BD1cXnt1CisQ%3D%3D 10.1038/sj.eye.6702498 16826241
9. M Funk K Kriechbaum F Prager T Benesch M Georgopoulos GJ Zlabinger U Schmidt-Erfurth 2009 Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with -bevacizumab Investig Ophthalmol Vis Sci 50 1025 1032 10.1167/iovs.08-2510
10. TU Krohne N Eter FG Holz CH Meyer 2008 Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans Am J Ophthalmol 146 508 512 1:CAS:528:DC%2BD1cXhtFektbfP 10.1016/j.ajo.2008.05.036 18635152
11. MD Rabena DJ Pieramici AA Castellarin MA Nasir RL Avery 2007 Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion Retina 27 419 425 10.1097/IAE.0b013e318030e77e 17420692 (Pubitemid 46624280)
12. F Rensch JB Jonas UH Spandau 2008 Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion Ophthalmologica 223 124 127 10.1159/000183844 19088494
13. F Prager S Michels K Kriechbaum M Georgopoulos M Funk W Geitzenauer K Polak U Schmidt-Erfurth 2009 Intravitreal bevacizumab (Avastin) for macular edema secondary to retinal vein occlusion - twelve-month results of a prospective clinical trial Br J Ophthalmol 93 452 526 1:STN:280: DC%2BD1M3jt1ejug%3D%3D 10.1136/bjo.2008.141085 19074916
14. GB Jaissle M Leitritz F Gelisken F Ziemssen KU Bartz-Schmidt P Szurman 2009 One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 247 27 33 1:CAS:528:DC%2BD1cXhtl2qtLjL 10.1007/s00417-008-0916-2 18696094
15. TC Kreutzer CS Alge AH Wolf D Kook J Burger R Strauss C Kunze C Haritoglou A Kampik S Priglinger 2008 Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion Br J Ophthalmol 92 351 355 1:STN:280:DC%2BD1c7ktFOnug%3D%3D 10.1136/bjo.2007.123513 18211925 (Pubitemid 351363529)
16. K Kriechbaum S Michels F Prager M Georgopoulos M Funk W Geitzenauer U Schmidt-Erfurth 2008 Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study Br J Ophthalmol 92 518 522 1:STN:280:DC%2BD1c3htVektA%3D%3D 10.1136/bjo.2007.127282 18211942 (Pubitemid 351497981)
17. A Stahl H Agostini LL Hansen N Feltgen 2007 Bevacizumab in retinal vein occlusion-results of a prospective case series Graefes Arch Clin Exp Ophthalmol 245 1429 1436 1:CAS:528:DC%2BD2sXhtVajs73L 10.1007/s00417-007-0569-6 17356824 (Pubitemid 47423323)
18. M Kondo N Kondo Y Ito S Kachi M Kikuchi TR Yasuma I Ota M Kensaku H Terasaki 2009 Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12 months and multiple regression analysis Retina 29 1242 1248 10.1097/IAE.0b013e3181aa8e20 19672216
19. GB Jaissle P Szurman K Bartz-Schmidt 2005 Recommendation for the procedure of intravitreal injections of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA) Klin Monatsbl Augenheilkd 222 390 395 1:STN:280:DC%2BD2Mzht1Snug%3D%3D 10.1055/s-2005-858231 15912456
20. Jaissle GB, Karl I, Bartz-Schmidt KU (2008) Einwilligung und Besonderheiten der Aufklärung im Off-Label-Bereich. In: Bartz-Schmidt KU, Ziemssen F (eds) Intravitreale Pharmakotherapie. Moderne Medikamente und ihre Anwendung am Auge. Schattauer, Stuttgart, pp 25-29
21. SR Sadda Z Wu AC Walsh L Richine J Dougall R Cortez LD LaBree 2006 Errors in retinal thickness measurements obtained by optical coherence tomography Ophthalmology 113 285 293 10.1016/j.ophtha.2005.10.005 16406542 (Pubitemid 43170778)
22. M Bolz M Ritter K Polak M Bolz M Ritter K Polak C Ahlers C Hirn C Prünte I Golbaz T Benesch U Schmidt-Erfurth 2008 The role of stratus OCT in anti-VEGF therapy: qualitative and quantitative assessment of neovascular AMD Ophthalmologe 105 650 655 1:CAS:528:DC%2BD1cXoslWqtLY%3D 10.1007/s00347-007- 1639-1 18273622
23. A Chan JS Duker TH Ko JG Fujimoto JS Schuman 2006 Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography Arch Ophthalmol 124 193 198 10.1001/archopht.124.2.193 16476888 (Pubitemid 43247068)
24. A Glacet-Bernard G Coscas A Chabanel A Zourdani F Lelong MM Samama 1996 Prognostic factors for retinal vein occlusion: prospective study of 175 cases Ophthalmology 103 551 560 1:STN:280:DyaK283gtVSnsA%3D%3D 8618752 (Pubitemid 26114223)
25. EJ Chung YT Hong SC Lee EJ Chung YT Hong SC Lee OW Kwon HJ Koh 2008 Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 246 1241 1247 1:CAS:528:DC%2BD1cXovFOnt7o%3D 10.1007/s00417-008-0866-8 18546006